BioSpace News Archive

Pharm Country

Free Technical Research Reports on Medical Research Stocks -- HTG Molecular Diagnostics, PerkinElmer, PRA Health Sciences, and Precipio

If you want a free Stock Review on HTGM, PKI, PRAH, and PRPO sign up now at https://stocktraderreport.com/registration/.

July 18, 2018
·
7 min read
Deals

Delphi Behavioral Health Group Announces Acquisition of Family Recovery Specialists

Leading Health Group Adds South Florida Family-focused Recovery Program to Roster

July 18, 2018
·
4 min read
Business

Kodiak Sciences Appoints Bassil I. Dahiyat, Ph.D. Robert A. Profusek, J.D. and Richard S. Levy, M.D. to its Board of Directors

Kodiak Sciences Inc. announced the appointments of Bassil I. Dahiyat, Ph.D., Robert A. Profusek, J.D., and Richard S. Levy, M.D. to its Board of Directors.

July 18, 2018
·
5 min read
Drug Development

Pfizer And Lilly Announce Positive Top-Line Results From Phase 3 Trial Of Tanezumab For The Treatment Of Osteoarthritis (OA) Pain

Tanezumab is also being evaluated for chronic low back pain (CLBP) and cancer pain (due to bone metastases).

July 18, 2018
·
9 min read
Business

Compugen Second Quarter 2018 Conference Call Scheduled for Wednesday, August 1, 2018 at 8:30 AM ET

Compugen Ltd. announced that the Company will release its second quarter 2018 financial results on Wednesday, August 1, 2018

July 18, 2018
·
1 min read
Business

Stock Yards Bancorp Names John L. Schutte to The Boards of Directors of the Company and Stock Yards Bank & Trust

Stock Yards Bancorp, Inc. announced that John L. Schutte has joined the Boards of Directors for both the Company and the Bank.

July 18, 2018
·
2 min read
Pharm Country

Hikma Acts to Ease Critical Shortage of Pain Medications Needed by US Hospitals and Their Patients

Leading Generic Pharmaceutical Company Increases Manufacturing Capacity to Produce and Release Significant Quantities of Scarce Medicines

July 18, 2018
·
2 min read
Business

Alimera Sciences to Report Second Quarter 2018 Results July 30, 2018

An accompanying conference call will be hosted by Dan Myers, Chief Executive Officer and Rick Eiswirth, President and Chief Financial Officer to discuss the results

July 18, 2018
·
1 min read
Deals

EUSA Pharma Announces Acquisition of Global Rights to SYLVANT® (siltuximab) from Janssen Sciences Ireland UC for $115 Million

Acquisition significantly boosts EUSA Pharma’s presence as a global biopharmaceutical company in oncology and rare disease

July 18, 2018
·
7 min read
SteadyHealth: Miscommunication Between HFEA and Fertility Clinics Obstructs Patient Access to Accurate Information

A total of 75,000 IVF cycles took place in the UK in 2016 and 2017, and 60 percent of UK-based fertility treatment is currently self-funded.

July 18, 2018
·
2 min read